Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal

Detalhes bibliográficos
Autor(a) principal: Santos, Sara Saurin dos
Data de Publicação: 2012
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
dARK ID: ark:/26339/001300000p09q
Texto Completo: http://repositorio.ufsm.br/handle/1/5981
Resumo: This work aimed the preparation of clotrimazole-loaded nanocapsule suspensions for vulvovaginal fungal infections treatment. For the first time, virgin coconut oil and medium chain triglycerides were used as an oil core of polymeric nanocapsules containing clotrimazole. The analytical method for quantification of this drug into nanoparticles was developed and validated. The method proved to be selective, linear, precise, accurate and robust. Using the method of interfacial deposition of preformed polymer, the nanoparticles were successfully prepared at three different concentrations of clotrimazole (1, 2 and 3 mg/mL). The physicochemical parameters measured were pH, particle diameter, polydispersity index, drug content, encapsulation efficiency, zeta potential and stability in storage during 60 days. The encapsulation efficiency was near to 100%, zeta potential was positive due to the cationic polymer employed, the pH was around 5.6 and drug contents were close to the theoretical values. The size distribution was nanometer (140-200 nm) with polydispersity index lower than 0.2. The formulations had adequate physicochemical characteristics and were stable during storage. Photodegradation studies have shown that the nanoencapsulation improved the stability of clotrimazole against UVC radiation compared to free drug solution after 14 hours of experiment. The in vitro drug release using the dialysis bag technique was characterized by a prolonged release. No burst effect was observed. Profilesare based on an anomalous transport and first order kinetics, regardless of the oil used. The in vitro microbiological test of nanocapsules suspensions was performed against Candida albicans and Candida glabrata susceptible and resistant to fluconazole by microdilution method. In combination with clotrimazole into nanoparticles, medium chain triglycerides was reported to have similar MICs of methanolic solution containing the oil and the drug. In addition to the antifungal activity in solution, coconut oil did not lose its activity after incorporation into the nanostructures and, in combination with drug, showed greater inhibition of microbial growth than the nanocapsules of medium chain triglycerides with clotrimazole. Finally nanoparticle suspensions were incorporated into hydrogels containing polymers with mucoadhesive properties, Pemulen® and Pullulan, which presented appropriate drug content, pH and spreadability. The formulations developed in this study represent promising alternatives for treatment of vulvovaginal candidiasis.
id UFSM_86c97f8a9f04fdd76655873de62ba1f7
oai_identifier_str oai:repositorio.ufsm.br:1/5981
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginalDevelopment of nano-scale formulations for the treatment of vulvovaginal candidiasisNanocápsulasCandidíase vulvovaginalÓleo de coco virgemClotrimazolHidrogéisNanocapsulesVulvovaginal candidiasisVirgin coconut oilClotrimazoleHydrogelsCNPQ::CIENCIAS DA SAUDE::FARMACIAThis work aimed the preparation of clotrimazole-loaded nanocapsule suspensions for vulvovaginal fungal infections treatment. For the first time, virgin coconut oil and medium chain triglycerides were used as an oil core of polymeric nanocapsules containing clotrimazole. The analytical method for quantification of this drug into nanoparticles was developed and validated. The method proved to be selective, linear, precise, accurate and robust. Using the method of interfacial deposition of preformed polymer, the nanoparticles were successfully prepared at three different concentrations of clotrimazole (1, 2 and 3 mg/mL). The physicochemical parameters measured were pH, particle diameter, polydispersity index, drug content, encapsulation efficiency, zeta potential and stability in storage during 60 days. The encapsulation efficiency was near to 100%, zeta potential was positive due to the cationic polymer employed, the pH was around 5.6 and drug contents were close to the theoretical values. The size distribution was nanometer (140-200 nm) with polydispersity index lower than 0.2. The formulations had adequate physicochemical characteristics and were stable during storage. Photodegradation studies have shown that the nanoencapsulation improved the stability of clotrimazole against UVC radiation compared to free drug solution after 14 hours of experiment. The in vitro drug release using the dialysis bag technique was characterized by a prolonged release. No burst effect was observed. Profilesare based on an anomalous transport and first order kinetics, regardless of the oil used. The in vitro microbiological test of nanocapsules suspensions was performed against Candida albicans and Candida glabrata susceptible and resistant to fluconazole by microdilution method. In combination with clotrimazole into nanoparticles, medium chain triglycerides was reported to have similar MICs of methanolic solution containing the oil and the drug. In addition to the antifungal activity in solution, coconut oil did not lose its activity after incorporation into the nanostructures and, in combination with drug, showed greater inhibition of microbial growth than the nanocapsules of medium chain triglycerides with clotrimazole. Finally nanoparticle suspensions were incorporated into hydrogels containing polymers with mucoadhesive properties, Pemulen® and Pullulan, which presented appropriate drug content, pH and spreadability. The formulations developed in this study represent promising alternatives for treatment of vulvovaginal candidiasis.Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorEste trabalho objetivou a preparação de suspensões de nanocápsulas contendo clotrimazol para o tratamento de infecções fúngicas vulvovaginais. Pela primeira vez, o óleo de coco virgem e os triglicerídeos de cadeia média foram empregados como núcleo oleoso de nanocápsulas poliméricas contendo clotrimazol. A metodologia analítica para a quantificação do fármaco nas nanopartículas foi desenvolvida e validada. O método mostrou-se seletivo, linear, preciso, exato e robusto. A partir do método de deposição interfacial do polímero pré-formado, as nanopartículas foram preparadas com sucesso em três concentrações diferentes de clotrimazol (1, 2 e 3 mg/mL). Os parâmetros físico-químicos avaliados foram pH, diâmetro de partícula, índice de polidispersão, teor, eficiência de encapsulamento, potencial zeta e estabilidade frente ao armazenamento por 60 dias. A eficiência de encapsulamento foi próxima a 100%, o valor do potencial zeta foi positivo devido ao polímero catiônico empregado, valor de pH em torno de 5,6 e teores de fármaco próximos aos teóricos. A distribuição de tamanho foi nanométrica (140-200 nm), com índice de polidispersão menor que 0,2. As formulações apresentaram características físico-químicas adequadas e foram estáveis durante o armazenamento. Estudos de fotodegradação mostraram que o nanoencapsulamento melhorou a estabilidade do clotrimazol sob radiação UVC, em comparação com a solução do fármaco livre, após 14 horas de experimento. A liberação do fármaco in vitro, a partir da técnica de sacos de diálise, foi caracterizada como uma liberação prolongada sem efeito burst, que foi mediada por transporte anômalo e seguiu cinética de primeira ordem, independente do óleo utilizado. As suspensões foram capazes de diminuir a velocidade de liberação do clotrimazol nas 24 horas de experimento. A partir do método de microdiluição, procedeu-se a avaliação microbiológica in vitro das suspensões de nanocápsulas contra Candida albicans e Candida glabrata sensíveis e resistentes ao fluconazol. Em combinação com o clotrimazol nas nanopartículas, os triglicerídeos de cadeia média apresentaram valores de CIMs semelhantes à solução metanólica contendo o óleo e o fármaco. Além de apresentar atividade antifúngica em solução, o óleo de coco não perdeu sua atividade após a incorporação na nanoestrutura e, em associação com o fármaco, apresentou maior inibição do crescimento microbiano do que as nanocápsulas de triglicerídeos de cadeia média com clotrimazol. Por fim, as suspensões nanoparticuladas foram incorporadas em hidrogéis contendo polímeros com propriedades mucoadesivas, Pemulen® e Pullulan, que apresentaram teor, pH e espalhabilidade adequados. As formulações desenvolvidas neste estudo representam alternativas promissoras para o tratamento da candidíase vulvovaginal.Universidade Federal de Santa MariaBRFarmáciaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCruz, Letíciahttp://lattes.cnpq.br/3095970241017527Farago, Paulo Vitorhttp://lattes.cnpq.br/0041349149649402Silva, Cristiane de Bona dahttp://lattes.cnpq.br/6029111646602279Santos, Sara Saurin dos2015-02-122015-02-122012-08-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfSANTOS, Sara Saurin dos. DEVELOPMENT OF NANO-SCALE FORMULATIONS FOR THE TREATMENT OF VULVOVAGINAL CANDIDIASIS. 2012. 118 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.http://repositorio.ufsm.br/handle/1/5981ark:/26339/001300000p09qporinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-10-19T16:59:27Zoai:repositorio.ufsm.br:1/5981Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-10-19T16:59:27Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
Development of nano-scale formulations for the treatment of vulvovaginal candidiasis
title Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
spellingShingle Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
Santos, Sara Saurin dos
Nanocápsulas
Candidíase vulvovaginal
Óleo de coco virgem
Clotrimazol
Hidrogéis
Nanocapsules
Vulvovaginal candidiasis
Virgin coconut oil
Clotrimazole
Hydrogels
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
title_full Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
title_fullStr Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
title_full_unstemmed Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
title_sort Desenvolvimento de formulações nanotecnológicas para o tratamento da candidíase vulvovaginal
author Santos, Sara Saurin dos
author_facet Santos, Sara Saurin dos
author_role author
dc.contributor.none.fl_str_mv Cruz, Letícia
http://lattes.cnpq.br/3095970241017527
Farago, Paulo Vitor
http://lattes.cnpq.br/0041349149649402
Silva, Cristiane de Bona da
http://lattes.cnpq.br/6029111646602279
dc.contributor.author.fl_str_mv Santos, Sara Saurin dos
dc.subject.por.fl_str_mv Nanocápsulas
Candidíase vulvovaginal
Óleo de coco virgem
Clotrimazol
Hidrogéis
Nanocapsules
Vulvovaginal candidiasis
Virgin coconut oil
Clotrimazole
Hydrogels
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Nanocápsulas
Candidíase vulvovaginal
Óleo de coco virgem
Clotrimazol
Hidrogéis
Nanocapsules
Vulvovaginal candidiasis
Virgin coconut oil
Clotrimazole
Hydrogels
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description This work aimed the preparation of clotrimazole-loaded nanocapsule suspensions for vulvovaginal fungal infections treatment. For the first time, virgin coconut oil and medium chain triglycerides were used as an oil core of polymeric nanocapsules containing clotrimazole. The analytical method for quantification of this drug into nanoparticles was developed and validated. The method proved to be selective, linear, precise, accurate and robust. Using the method of interfacial deposition of preformed polymer, the nanoparticles were successfully prepared at three different concentrations of clotrimazole (1, 2 and 3 mg/mL). The physicochemical parameters measured were pH, particle diameter, polydispersity index, drug content, encapsulation efficiency, zeta potential and stability in storage during 60 days. The encapsulation efficiency was near to 100%, zeta potential was positive due to the cationic polymer employed, the pH was around 5.6 and drug contents were close to the theoretical values. The size distribution was nanometer (140-200 nm) with polydispersity index lower than 0.2. The formulations had adequate physicochemical characteristics and were stable during storage. Photodegradation studies have shown that the nanoencapsulation improved the stability of clotrimazole against UVC radiation compared to free drug solution after 14 hours of experiment. The in vitro drug release using the dialysis bag technique was characterized by a prolonged release. No burst effect was observed. Profilesare based on an anomalous transport and first order kinetics, regardless of the oil used. The in vitro microbiological test of nanocapsules suspensions was performed against Candida albicans and Candida glabrata susceptible and resistant to fluconazole by microdilution method. In combination with clotrimazole into nanoparticles, medium chain triglycerides was reported to have similar MICs of methanolic solution containing the oil and the drug. In addition to the antifungal activity in solution, coconut oil did not lose its activity after incorporation into the nanostructures and, in combination with drug, showed greater inhibition of microbial growth than the nanocapsules of medium chain triglycerides with clotrimazole. Finally nanoparticle suspensions were incorporated into hydrogels containing polymers with mucoadhesive properties, Pemulen® and Pullulan, which presented appropriate drug content, pH and spreadability. The formulations developed in this study represent promising alternatives for treatment of vulvovaginal candidiasis.
publishDate 2012
dc.date.none.fl_str_mv 2012-08-21
2015-02-12
2015-02-12
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv SANTOS, Sara Saurin dos. DEVELOPMENT OF NANO-SCALE FORMULATIONS FOR THE TREATMENT OF VULVOVAGINAL CANDIDIASIS. 2012. 118 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.
http://repositorio.ufsm.br/handle/1/5981
dc.identifier.dark.fl_str_mv ark:/26339/001300000p09q
identifier_str_mv SANTOS, Sara Saurin dos. DEVELOPMENT OF NANO-SCALE FORMULATIONS FOR THE TREATMENT OF VULVOVAGINAL CANDIDIASIS. 2012. 118 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2012.
ark:/26339/001300000p09q
url http://repositorio.ufsm.br/handle/1/5981
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmácia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
BR
Farmácia
UFSM
Programa de Pós-Graduação em Ciências Farmacêuticas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1815172370576441344